1
TITLE: Primary results of the phase III JAVELIN head & neck 100 trial: Avelumab plus chemoradiotherapy (CRT) followed by avelumab maintenance vs CRT in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN)
AUTHORS: Cohen, EE; Ferris, RL; Psyrri, A; Haddad, R; Tahara, M; Bourhis, J; Harrington, KJ; Chang, PMH; Lin, JC; Razaq, M; Teixeira, MM; Lovey, J; Chamois, J; Rueda Dominguez, AR; Hu, C; Dvorkin, M; De Beukelaer, S; Pavlov, D; Thurm, H; Lee, N;
PUBLISHED: 2020, SOURCE: ESMO Virtual Congress in ANNALS OF ONCOLOGY, VOLUME: 31
INDEXED IN: WOS